Pubblicazioni

LONG-TERM OUTCOME OF ALTERNATING NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY AS FIRST-LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A PHASE 2 STUDY OF THE GIMEMA CML WORKING PARTY

2015 - HAEMATOLOGICA

Gugliotta, G; Castagnetti, F; Breccia, M; Gozzini, A; Stagno, F; Rege-Cambrin, G; Carella, Am; Luciano, L; Specchia, G; Abruzzese, E; Martino, B; Usala, E; Rossi, G; Bocchia, M; Cavazzini, F; Tiribelli, M; Venturi, C; Soverini, S; Alimena, G; Cavo, M; Pane, F; Martinelli, G; Saglio, G; Rosti, G; Baccarani, M

A RETROSPECTIVE MULTICENTRE COMPARISON OF INTENSIVE CHEMOTHERAPY WITH AZACITIDINE FOR THE FRONT LINE TREATMENT OF ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS

2015 - HAEMATOLOGICA

Maurillo, L; Buccisano, F; Voso, Mt; Fianchi, L; Papayannidis, C; Gaidano, Gl; Breccia, M; Musto, R; Di Veroli, A; Martinelli, G; Lunghi, M; Lessi, F; Del Principe, Mi; Ramadan, Sm; Suciu, S; Amadori, S; Venditti, A

DEEP MOLECULAR RESPONSE TO NILOTINIB AS FIRST-LINE TREATMENT OF BCR-ABL plus CHRONIC MYELOID LEUKEMIA

2015 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Rossi, G; Stagno, F; Turri, D; Pregno, P; Tiribelli, M; Trabacchi, E; Martino, B; Carella, Am; Isidori, A; Pierri, I; Salvucci, M; Specchia, G; Levato, L; Avanzini, P; Capalbo, S; Merli, A; Maino, E; Binotto, G; Bochicchio, Mt; Soverini, S; Cavo, M; Alimena, G; Martinelli, G; Saglio, G; Pane, F; Baccarani, M; Rosti, G

LONG-TERM OUTCOME OF ALTERNATING NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY AS FRONTLINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A PHASE 2 STUDY OF THE GIMEMA CML WORKING PARTY

2015 - HAEMATOLOGICA

Gugliotta, G; Castagnetti, F; Breccia, M; Gozzini, A; Stagno, F; Rege-Cambrin, G; Carella, Am; Luciano, L; Abruzzese, E; Martino, B; Usala, E; Rossi, G; Bocchia, M; Cavazzini, F; Tiribelli, M; Luatti, S; Venturi, C; Soverini, S; Cavo, M; Specchia, G; Alimena, G; Pane, F; Martinelli, G; Saglio, G; Rosti, G; Baccarani, M

IS HIGH PLATELET COUNT AT DIAGNOSIS OF ESSENTIAL THROMBOCYTHEMIA A PROTECTIVE FACTOR FOR THROMBOSIS?

2015 - HAEMATOLOGICA

Andriani, A; Latagliata, R; Cedrone, M; Di Veroli, A; Spirito, F; Ruscio, C; Crescenzi, Sl; Porrini, R; Di Giandomenico, J; Villiva, N; Spadea, A; Rago, A; De Gregoris, C; Mastini, C; Anaclerico, B; De Muro, M; Felici, S; Breccia, M; Montefusco, E; Bagnato, A; Cimino, G; Majolino, I; Alimena, G; Montanaro, M

CARDIOVASCULAR EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FIRST-LINE: AN ANALISYS OF THE GIMEMA CML WP

2015 - HAEMATOLOGICA

Gugliotta, G; Castagnetti, F; Breccia, M; Stagno, F; Martino, B; Fava, C; Luciano, L; Gozzini, A; Carella, Am; Abruzzese, E; Levato, L; Usala, E; Rossi, G; Bocchia, M; Tiribelli, M; Cavazzini, F; Salvucci, M; Cedrone, M; Trabacchi, E; Binotto, G; Venturi, C; Soverini, S; Cavo, M; Specchia, G; Alimena, G; Pane, F; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G

LONG-TERM OUTCOME TO FIRST-LINE IMATINIB ACCORDING TO 2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA: A GIMEMA CML WP ANALYSIS

2015 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Stagno, F; Iurlo, A; Albano, F; Abruzzese, E; Martino, B; Levato, L; Intermesoli, T; Pregno, P; Rossi, G; Gherlinzoni, F; Leoni, P; Cavazzini, F; Ferrero, D; Usala, E; Bocchia, M; Tiribelli, M; Montefusco, E; Sica, S; Venturi, C; Soverini, S; Cavo, M; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G

LONG TERM OUTCOME OF INTERMITTENT IMATINIB TREATMENT POLICY FOR MANAGING CHRONIC MYELOID LEUKEMIA IN THE ELDERLY

2015 - HAEMATOLOGICA

Russo, D; Malagola, M; Skert, C; Cancelli, V; Turri, D; Pregno, P; Pierri, I; Fogli, M; Testoni, N; De Vivo, A; Castagnetti, F; Pungolino, E; Stagno, F; Breccia, M; Martino, B; Intermesoli, T; Cambrin, Gr; Nicolini, G; Abruzzese, E; Tiribelli, M; Bigazzi, C; Usala, E; Russo, S; Russo-Rossi, A; Lunghi, M; Bocchia, M; D'Emilio, A; Santini, V; Girasoli, M; Di Lorenzo, R; Cesana, Bm; Soverini, S; Martinelli, G; Rosti, G; Baccarani, M

SMOOTHENED (SMO) INHIBITOR LDE225 COMBINED WITH NILOTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) RESISTANT/INTOLERANT (R/I) TO AT LEAST 1 PRIOR TYROSINE KINASE INHIBITOR: A PHASE 1B STUDY

2015 - HAEMATOLOGICA

Ottmann, O; Charbonnier, A; Stegelmann, F; Breccia, M; Steegmann, Jl; Olavarria, E; Jevtic, S; Cota, M; Scheuer, N; Lipton, Jh

RECEIVER OPERATING CHARACTERISTIC ANALYSIS AS A TOOL TO IDENTIFY THRESHOLD VALUES OF CONTINOUS RISK FACTORS FOR THROMBOSIS AND SURVIVAL IN ESSENTIAL THROMBOCITEMIA: A RETROSPECTIVE ANALYSIS ON 1250 PATIENTS

2015 - HAEMATOLOGICA

Montanaro, M; Latagliata, R; Cedrone, M; Spirito, F; Ruscio, C; Crescenzi, Sl; Porrini, R; Di Giandomenico, J; Di Veroli, A; Villiva, N; Spadea, A; Rago, A; De Gregoris, C; Mastini, C; De Muro, M; Felici, S; Breccia, M; Montefusco, E; Bagnato, A; Anaclerico, B; Cimino, G; Majolino, I; Alimena, G; Andriani, A

SEX CORRELATED WITH DIFFERENCES IN LONG-TERM OUTCOME IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB

2015 - HAEMATOLOGICA

Breccia, M; Colafigli, G; Molica, M; De Angelis, F; Quattrocchi, L; Latagliata, R; Mancini, M; Diverio, D; Alimena, G

EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS (TKIS)

2015 - HAEMATOLOGICA

Sora, F; Autore, F; Alimena, G; Annunziata, M; Avanzini, P; Bocchia, M; Breccia, M; Celesti, F; Chiusolo, P; Crugnola, M; Endri, M; Fava, C; Galimberti, S; Gozzini, A; Iurlo, A; Latagliata, R; Musto, P; Porrini, R; Pregno, R; Cambrin, Gr; Sica, S

EFFICACY OF RUXOLITINIB IN MYELOFIBROSIS PATIENTS WITHOUT SPLENOMEGALY

2015 - HAEMATOLOGICA

Palandri, F; Polverelli, N; Benevolo, G; Latagliata, R; Catani, L; Nicolosi, M; Perricone, M; Sollazzo, D; Colafigli, G; Campana, A; Vitolo, U; Alimena, G; Martinelli, G; Breccia, M; Cavo, M; Vianelli, N

"REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA

2015 - HAEMATOLOGICA

Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Luciano, L; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Avanzini, P; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Tiribelli, M; Rizzo, M; Endri, M; Antolino, A; Breccia, M; Vigneri, P; Trawinska, Mm; Guarini, A; Alimena, G

LONG-TERM VALUE OF FLUCTUATION OF MOLECULAR RESPONSES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB

2015 - HAEMATOLOGICA

Breccia, M; Colafigli, G; Molica, M; De Angelis, F; Quattrocchi, L; Latagliata, R; Mancini, M; Diverio, D; Alimena, G

PML/RAR KINETICS AND IMPACT OF FLT3-ITD MUTATIONS IN NEWLY DIAGNOSED LOW-INTERMEDIATE RISK ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ATRA AND ATO OR ATRA AND CHEMOTHERAPY

2015 - HAEMATOLOGICA

Cicconi, L; Divona, M; Ciardi, C; Ottone, T; Ferrantini, A; Lavorgna, S; Alfonsi, V; Paoloni, F; Vignetti, M; Avvisati, G; Ferrara, F; Fazi, P; Di Bona, E; Specchia, G; Breccia, M; Cerqui, E; Sborgia, M; Cazzola, M; Melillo, L; Carella, Am; Morra, E; Kropp, Mg; Rambaldi, A; La Nasa, G; Luppi, M; Ciceri, F; Finizio, O; Levis, A; Sica, S; Fabiano, F; Amadori, S; Voso, Mt; Mandelli, F; Lo Coco, F

A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS

2015 - HAEMATOLOGICA

Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, E; Stagno, F; Bonifacio, M; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G